Patient Opportunity Trust Class IS
MVISX
NASDAQ
| Weiss Ratings | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Patient Capital Management | |||
| Manager/Tenure (Years) | Samantha McLemore (18), Christina Malbon (3) | |||
| Website | http://www.patientcapitalmanagement.com | |||
| Fund Information | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Patient Opportunity Trust Class IS | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Mid Cap | |||
| Prospectus Objective | Growth | |||
| Inception Date | Aug 22, 2018 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.17% | |||
| Dividend | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.09% | |||
| Asset Allocation | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -0.81% | |||
| Stock | 97.53% | |||
| U.S. Stock | 91.44% | |||
| Non-U.S. Stock | 6.09% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.56% | |||
| Convertible | 0.00% | |||
| Other Net | 2.72% | |||
| Price History | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -0.69% | |||
| 30-Day Total Return | -4.20% | |||
| 60-Day Total Return | -6.76% | |||
| 90-Day Total Return | -6.67% | |||
| Year to Date Total Return | 10.48% | |||
| 1-Year Total Return | 18.17% | |||
| 2-Year Total Return | 47.56% | |||
| 3-Year Total Return | 115.13% | |||
| 5-Year Total Return | 42.78% | |||
| Price | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $59.86 | |||
| 1-Month Low NAV | $59.63 | |||
| 1-Month High NAV | $62.46 | |||
| 52-Week Low NAV | $48.57 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $64.62 | |||
| 52-Week High Price (Date) | Sep 03, 2026 | |||
| Beta / Standard Deviation | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.38 | |||
| Standard Deviation | 19.61 | |||
| Balance Sheet | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 2.01B | |||
| Operating Ratios | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.33% | |||
| Turnover Ratio | 27.00% | |||
| Performance | MVISX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 47.43% | |||
| Last Bear Market Total Return | -29.42% | |||